| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8623779 | Seminars in Arthritis and Rheumatism | 2018 | 42 Pages |
Abstract
The US-CLARA is valid and sensitive tool to assess disease activity in RA.
Keywords
HDACDAIOMERACTDAS28DMARDsEULARACPAmetacarpophalangealREMSDAINRSACRROCTJCSJCPaGAMDAMCPSRMESRAUCRheumatoid arthritisanti-citrullinated protein antibodiesRemissionEffect sizeProximal interphalangealLDARoaddisease-modifying anti-rheumatic drugsBiological therapieserythrocyte sedimentation rateUltrasonographybody mass indexBMIClinical disease activity indexProSrheumatoid factorconfidence intervalUltrasoundlow disease activityPower DopplerEuropean League Against RheumatismOutcome measuresGray scalenumerical rating scalearea under the curvePatient-reported outcomesC-reactive proteinCRPPiPAmerican College of Rheumatologyreceiver operating characteristic
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Fausto MD, PhD, Marco MD, Florenzo MD, Anna Laura MD, Oscar Massimiliano MD, Raffaele MD, Rosario MD, Giuseppe MD, Leonardo MD, Federica MD, Piercarlo MD, Antonio MD, Elisa MD, Giovanni MD, Gianfranco MD,